MedImmune's appetite for truffles

MedImmune Inc.'s biggest deals - the acquisitions of U.S. Bioscience Inc. and Aviron - were been geared toward growing its top line. But in the past year the company has signed four smaller deals aimed at growing its pipeline without adding a lot

Read the full 434 word article

How to gain access

Continue reading with a
two-week free trial.